Semaglutide side effects in women: what changes, what passes and what to watch

The side effects women report most, and why they peak early

The GI effects of semaglutide (nausea, vomiting, diarrhoea, constipation, belching and acid reflux) dominate the early weeks for many women. They arise because semaglutide slows gastric emptying and acts on appetite-regulating centres in the brain; both effects are intentional for weight management, but they come with short-term discomfort for some people. The NHS medicines page for semaglutide lists nausea as the most commonly reported effect, alongside diarrhoea, constipation and indigestion.

In clinical trials, the majority of GI effects were mild to moderate and transient, clustering around the start of treatment and each dose step-up. Most women find they are at their worst for the first few days after an increase, then fade. Fatigue and headache also feature for some, particularly in the first month. The graduated titration schedule exists partly for this reason — the body is given time to adapt before the dose moves higher.

Women specifically sometimes notice that appetite suppression is sharper than expected on lower doses, which can affect meal patterns and, in turn, energy. Eating smaller portions of protein-rich food and staying well hydrated tends to ease symptoms; your prescriber or a dietitian can give personalised advice. If nausea is persistent rather than intermittent, that is worth flagging rather than waiting out. Our broader semaglutide side effects overview covers the full picture across populations, and you can also read about what to expect from side effects from semaglutide as treatment progresses.

Side effects that are specific to, or more relevant for, women on semaglutide

Hormonal considerations add a layer of complexity for women. The question our prescribers hear most often is whether semaglutide affects hormonal contraception. Current NHS guidance suggests there is no equivalent evidence for semaglutide reducing oral contraceptive pill absorption in the way that has been established for tirzepatide. That said, slowed gastric emptying can theoretically affect the absorption timing of any orally taken medicine, so it is sensible to raise this with your prescriber, particularly during the dose-increase phase.

Women on oral HRT face a similar practical question. NHS England advises that transdermal preparations, such as patches or gels, sidestep the absorption uncertainty during GLP-1 treatment; if you take oral HRT, a conversation with your GP about format is worthwhile. You can read more about the side effects of Wegovy specifically in women for a deeper look at this interaction.

Menstrual cycle changes are sometimes reported anecdotally during weight loss, including on semaglutide, but the evidence base here is limited. Changes in body weight can affect hormonal balance; this is not unique to semaglutide and is generally expected to normalise as weight stabilises. Separately, semaglutide is not recommended during pregnancy, while breastfeeding or if you are actively trying to conceive. If any of these situations apply, a frank conversation with your prescriber before or during treatment is essential. Under-18s are not licensed for this treatment.

When to get medical help without waiting

Most side effects from semaglutide are uncomfortable rather than dangerous. A few are exceptions.

Severe stomach pain that does not pass, especially pain that spreads towards the back and is accompanied by vomiting, needs urgent medical assessment. In January 2026 the MHRA issued a Drug Safety Update reinforcing that acute pancreatitis is a known but uncommon risk with GLP-1 medicines; the MHRA Drug Safety Update sets out the full guidance. Do not wait for your next scheduled review if this symptom pattern appears, call NHS 111 or go to A&E if the pain is severe.

Signs of a serious allergic reaction, including swelling of the face, lips or throat, difficulty breathing or a severe skin rash, also need emergency attention. Persistent vomiting or diarrhoea that prevents you staying hydrated can lead to kidney strain over time; if you cannot keep fluids down for more than a day, seek advice. Sudden changes in vision in anyone also managing diabetes should be reported promptly.

For anything that does not feel right but is not an emergency, the nume support team is available seven days a week, and your prescriber can be reached through your aftercare pathway. Any suspected side effect can be reported to the MHRA directly via the Yellow Card scheme, that link is in the safety-facts panel above. Some women find it reassuring to read about how long semaglutide side effects typically last before making a decision about continuing treatment.

Making a considered decision: staying on treatment versus pausing

Side effects are one of the main reasons women pause or stop semaglutide before reaching a maintenance dose. That decision deserves clinical input, not a judgment call made alone at the kitchen counter. For many women, the discomfort in the first four to eight weeks is the worst of it; the experience often improves markedly once the body has adapted to a stable dose.

If side effects are significantly affecting daily life, slowing the titration pace is one option a prescriber may consider. That is not the same as stopping. Stopping abruptly and restarting from scratch resets the adjustment curve. What a pause looks like in practice, the timing around it, and whether the dose should be held rather than reduced, are prescriber decisions rather than self-managed ones.

Stopping treatment also has its own considerations, some women notice changes in appetite or bowel habit in the weeks after. If that is relevant to you, the page on constipation after stopping Wegovy may be useful context.

Semaglutide is a prescription-only medicine; what matters most is that the choice is made with full information and clinical support. Our prescribers discuss side effects, including those specific to women, as part of every consultation, not as a formality, but because it shapes whether treatment is the right fit and what a sensible plan looks like. Check your eligibility to start that conversation.